<p><strong>Neonates</strong>: Albendazole is not normally used in neonates.<br />
<br />
<strong>Children</strong>: Reduction of the dose from 400 mg to 200 mg may be indicated in children weighing less than 10 kg but there are no grounds for a general reduction in dosage to children.<br />
<br />
<strong>Pregnant woman</strong>: Albendazole should not be given during pregnancy or women thought to be pregnant. No information is available on placental transfer.<br />
<br />
<strong>Concurrent disease</strong>: There is no evidence to suggest that dose should be altered in renal, hepatic or cardiac failure.</p>